StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron Pharma (REGN) PT Raised to $352 at Cowen
November 5, 2019 3:42 PM
Cowen analyst Yaron Werber raised the price target on Regeneron Pharma (NASDAQ: REGN) to $352.00 (from $349.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Regeneron Pharma (REGN) PT Raised to $352 at BMO Capital
November 5, 2019 3:43 PM